Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Davis

Showing results (261-270 of 437) with videos related to

Pageof 44
Sort By:
Schizophrenia Research|July 21, 2015
Effects of transcranial direct current stimulation (tDCS) on cognition, symptoms, and smoking in schizophrenia: A randomized controlled studyRobert C Smith, Sylvia Boules, Sanela Mattiuz, et al.
Systematic Reviews|August 3, 2021
Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trialsJohannes Schneider-Thoma, Angelika Kapfhammer, Dongfang Wang, et al.
The Journal of Clinical Psychiatry|January 17, 2012
Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approachIra D Glick, Christoph U Correll, A Carlo Altamura, et al.
Rheumatology and Therapy|November 10, 2020
Effects of Therapies on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-AnalysisParas Karmacharya, Ravi Shahukhal, Cynthia S Crowson, et al.
Bipolar Disorders|April 10, 2014
Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorderMark Weiser, Shimon Burshtein, Ari A Gershon, et al.
The Journal of Rheumatology|July 3, 2023
Validating the Fracture Risk Assessment Tool Score in a US Population-Based Study of Patients With Rheumatoid ArthritisJehan Mousa, Madeline N Peterson, Cynthia S Crowson, et al.
Clinical Rheumatology|May 31, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritisYuan Liu, Jane M Jaquith, Kathleen Mccarthy-Fruin, et al.
The American Surgeon|February 14, 2023
Effect of Smoking History on 30-Day Morbidity Following Bariatric SurgeryNicolas Fuentes, Jose A Reyes, Benjamin Souferi, et al.
Schizophrenia Bulletin|January 22, 2021
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled TrialsMark Weiser, Daisy Zamora, Linda Levi, et al.
Arthritis and Rheumatism|October 31, 2007
The widening mortality gap between rheumatoid arthritis patients and the general populationAngel Gonzalez, Hilal Maradit Kremers, Cynthia S Crowson, et al.
Pageof 44

Showing results (261-270 of 437) with videos related to

Sort By:
Pageof 44
Schizophrenia Research|July 21, 2015
Effects of transcranial direct current stimulation (tDCS) on cognition, symptoms, and smoking in schizophrenia: A randomized controlled studyRobert C Smith, Sylvia Boules, Sanela Mattiuz, et al.
Systematic Reviews|August 3, 2021
Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trialsJohannes Schneider-Thoma, Angelika Kapfhammer, Dongfang Wang, et al.
The Journal of Clinical Psychiatry|January 17, 2012
Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approachIra D Glick, Christoph U Correll, A Carlo Altamura, et al.
Rheumatology and Therapy|November 10, 2020
Effects of Therapies on Cardiovascular Events in Ankylosing Spondylitis: A Systematic Review and Meta-AnalysisParas Karmacharya, Ravi Shahukhal, Cynthia S Crowson, et al.
Bipolar Disorders|April 10, 2014
Allopurinol for mania: a randomized trial of allopurinol versus placebo as add-on treatment to mood stabilizers and/or antipsychotic agents in manic patients with bipolar disorderMark Weiser, Shimon Burshtein, Ari A Gershon, et al.
The Journal of Rheumatology|July 3, 2023
Validating the Fracture Risk Assessment Tool Score in a US Population-Based Study of Patients With Rheumatoid ArthritisJehan Mousa, Madeline N Peterson, Cynthia S Crowson, et al.
Clinical Rheumatology|May 31, 2020
Immune checkpoint inhibitor-induced inflammatory arthritis: a novel clinical entity with striking similarities to seronegative rheumatoid arthritisYuan Liu, Jane M Jaquith, Kathleen Mccarthy-Fruin, et al.
The American Surgeon|February 14, 2023
Effect of Smoking History on 30-Day Morbidity Following Bariatric SurgeryNicolas Fuentes, Jose A Reyes, Benjamin Souferi, et al.
Schizophrenia Bulletin|January 22, 2021
Adjunctive Aspirin vs Placebo in Patients With Schizophrenia: Results of Two Randomized Controlled TrialsMark Weiser, Daisy Zamora, Linda Levi, et al.
Arthritis and Rheumatism|October 31, 2007
The widening mortality gap between rheumatoid arthritis patients and the general populationAngel Gonzalez, Hilal Maradit Kremers, Cynthia S Crowson, et al.
Pageof 44